z-logo
open-access-imgOpen Access
The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity
Author(s) -
Shen Yue,
Eades William,
Yan Bingfang
Publication year - 2021
Publication title -
hepatology communications
Language(s) - English
Resource type - Journals
ISSN - 2471-254X
DOI - 10.1002/hep4.1736
Subject(s) - context (archaeology) , transfection , prodrug , medicine , virology , adverse effect , pandemic , covid-19 , pharmacology , cell culture , biology , disease , infectious disease (medical specialty) , paleontology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here